| |
| |
|
| Insider
Information: |
Cavazza Paolo |
| Relationship: |
10% Owner |
| City: |
Lugano |
| State: |
V8 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
10,656,982 |
|
|
Indirect Shares
|
18,340,916 |
|
|
| Direct
Value |
$476,546 |
|
|
|
Indirect Value
|
$1,328,416 |
|
|
| Total
Shares |
28,997,898 |
|
|
| Total
Value |
$1,804,962 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -31.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sciclone Pharmaceuticals Inc |
SCLN |
10% Owner |
2008-01-30 |
822,815 |
2008-01-30 |
8,635,831 |
Premium* |
|
|
Questcor Pharmaceuticals Inc |
QCOR |
10% Owner |
2005-04-15 |
8,643,397 |
2005-04-15 |
4,922,156 |
Premium* |
|
|
Regenerx Biopharmaceuticals Inc |
RGN |
10% Owner |
|
0 |
2021-06-30 |
1,500,000 |
Premium* |
|
|
Soligenix Inc Common |
SNGX |
10% Owner |
2010-06-18 |
1,190,770 |
2010-06-18 |
3,282,929 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SCLN |
Sciclone Pharmaceuticals ... |
officerTitle |
– – • |
2006-02-02 |
4 |
B |
$0.00 |
$107,463 |
I/I |
44,300 |
536,441 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
officerTitle |
– – • |
2006-02-02 |
4 |
B |
$0.00 |
$0 |
D/D |
0 |
572,815 |
2.37 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2006-03-14 |
4 |
B |
$2.69 |
$134,982 |
I/I |
50,000 |
561,441 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2006-03-14 |
4 |
OE |
$2.50 |
$125,000 |
I/I |
50,000 |
822,152 |
|
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2006-06-13 |
4 |
OE |
$2.50 |
$87,750 |
I/I |
35,100 |
857,252 |
|
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2006-06-14 |
4 |
B |
$2.49 |
$124,500 |
I/I |
50,000 |
611,441 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2006-06-16 |
4 |
OE |
$2.50 |
$567,250 |
I/I |
226,900 |
1,084,152 |
|
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2006-08-09 |
4 |
OE |
$2.50 |
$6,250 |
I/I |
2,500 |
1,086,652 |
|
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2006-09-15 |
4 |
OE |
$2.50 |
$118,750 |
I/I |
47,500 |
1,134,152 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2006-12-15 |
4 |
OE |
$2.50 |
$773,250 |
I/I |
309,300 |
765,841 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2006-12-15 |
4 |
OE |
$2.50 |
$625,000 |
D/D |
250,000 |
822,815 |
0 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2007-10-01 |
4 |
B |
$1.96 |
$27,346 |
I/I |
13,952 |
6,081,963 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2007-10-02 |
4 |
B |
$1.93 |
$20,043 |
I/I |
10,385 |
6,092,348 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2007-10-15 |
4 |
B |
$2.05 |
$41,000 |
I/I |
20,000 |
6,112,348 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2007-10-16 |
4 |
B |
$2.06 |
$102,950 |
I/I |
50,000 |
6,162,348 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2007-10-17 |
4 |
B |
$2.05 |
$51,248 |
I/I |
25,000 |
6,187,348 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2007-10-18 |
4 |
B |
$2.05 |
$33,351 |
I/I |
16,269 |
6,203,617 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2007-10-19 |
4 |
B |
$2.05 |
$51,250 |
I/I |
25,000 |
6,228,617 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2007-11-01 |
4 |
B |
$2.05 |
$51,250 |
I/I |
25,000 |
6,253,617 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2007-11-02 |
4 |
B |
$2.05 |
$59,636 |
I/I |
29,119 |
6,282,736 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2007-11-05 |
4 |
B |
$2.05 |
$82,362 |
I/I |
40,255 |
6,322,991 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2007-11-07 |
4 |
B |
$2.05 |
$34,169 |
I/I |
16,684 |
6,339,675 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2007-11-08 |
4 |
B |
$2.05 |
$1,380 |
I/I |
673 |
6,340,348 |
1.42 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2007-11-13 |
4 |
B |
$2.04 |
$111,575 |
I/I |
54,640 |
6,394,988 |
1.5 |
- |
|
| SCLN |
Sciclone Pharmaceuticals ... |
10% Owner |
– – • |
2008-01-11 |
4 |
B |
$2.00 |
$55,982 |
I/I |
28,001 |
6,422,989 |
1.5 |
- |
|
140 Records found
|
|
Page 5 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
